Age

12–17

Sex

ALL

Healthy volunteers

Not accepted

Patient is willing and able to provide assent and willing to complete all aspects of the study
Patient's parent or legal guardian willing and able to provide consent
Male or female patients 12 through 17 years of age (inclusive)
Clinical diagnosis of either schizophrenia or bipolar I disorder

Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer
A positive test for drugs of abuse

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents